Physician profile
Robert Coleman
NPI 1225075476
$998.23
in general payments reported to CMS, 2019-2025
19 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.97 · 2020: $32.70 · 2021: $64.02 · 2022: $184 · 2023: $392 · 2024: $107 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $274.07 | 2022-2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $189.87 | 2021-2025 | Nuzyra |
| Sebela Pharmaceuticals INC. | $81.94 | 2019-2023 | Naftin |
| Stryker Corporation | $80.54 | 2022-2024 | N/A, Prophecy, 7 X 23mm Citrelock Implant |
| Treace Medical Concepts, INC. | $76.67 | 2023-2025 | |
| Melinta Therapeutics, LLC | $42.41 | 2022 | |
| Peerless Surgical INC. | $41.95 | 2025 | |
| Nevro Corp. | $27.56 | 2023-2024 | Senza |
| Amgen INC. | $26.70 | 2024 | Krystexxa |
| Globus Medical, INC. | $24.62 | 2025 | Senza |
| Nabriva Therapeutics, Plc | $17.99 | 2021 | |
| Glenmark Therapeutics INC. | $17.00 | 2019 | |
| Horizon Therapeutics Plc | $14.45 | 2022 | |
| Bioventus LLC | $14.08 | 2022 | |
| Medtronic, INC. | $14.00 | 2025 | Intellis Adaptivestim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $13.97 | 2025 | Irrisept |
| Orthofix Medical, INC. | $13.93 | 2020 | |
| Averitas Pharma INC. | $13.65 | 2023 | Qutenza |
| Paragon 28, INC. | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.